FDA Accuses Two Manufacturers of Multiple GMP Violations

Drug Industry Daily
A A
The FDA is accusing two companies — one a dietary supplement manufacturer and one an API maker — of committing a multitude of GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily